» Articles » PMID: 39178841

Chemoproteomics Reveals Immunogenic and Tumor-associated Cell Surface Substrates of Ectokinase CK2α

Overview
Journal Cell Chem Biol
Publisher Cell Press
Specialty Biochemistry
Date 2024 Aug 23
PMID 39178841
Authors
Affiliations
Soon will be listed here.
Abstract

Foreign epitopes for immune recognition provide the basis of anticancer immunity. Due to the high concentration of extracellular adenosine triphosphate in the tumor microenvironment, we hypothesized that extracellular kinases (ectokinases) could have dysregulated activity and introduce aberrant phosphorylation sites on cell surface proteins. We engineered a cell-tethered version of the extracellular kinase CK2α, demonstrated it was active on cells under tumor-relevant conditions, and profiled its substrate scope using a chemoproteomic workflow. We then demonstrated that mice developed polyreactive antisera in response to syngeneic tumor cells that had been subjected to surface hyperphosphorylation with CK2α. Interestingly, these mice developed B cell and CD4 T cell responses in response to these antigens but failed to develop a CD8 T cell response. This work provides a workflow for probing the extracellular phosphoproteome and demonstrates that extracellular phosphoproteins are immunogenic even in a syngeneic system.

References
1.
Trembley J, Wang G, Unger G, Slaton J, Ahmed K . Protein kinase CK2 in health and disease: CK2: a key player in cancer biology. Cell Mol Life Sci. 2009; 66(11-12):1858-67. PMC: 4385580. DOI: 10.1007/s00018-009-9154-y. View

2.
Tao J, Li H, Li Q, Yang Y . CD109 is a potential target for triple-negative breast cancer. Tumour Biol. 2014; 35(12):12083-90. DOI: 10.1007/s13277-014-2509-5. View

3.
Yalak G, Ehrlich Y, Olsen B . Ecto-protein kinases and phosphatases: an emerging field for translational medicine. J Transl Med. 2014; 12:165. PMC: 4071215. DOI: 10.1186/1479-5876-12-165. View

4.
Hu E, Rubin C . Expression of wild-type and mutated forms of the catalytic (alpha) subunit of Caenorhabditis elegans casein kinase II in Escherichia coli. J Biol Chem. 1990; 265(33):20609-15. View

5.
Veatch J, Singhi N, Srivastava S, Szeto J, Jesernig B, Stull S . A therapeutic cancer vaccine delivers antigens and adjuvants to lymphoid tissues using genetically modified T cells. J Clin Invest. 2021; 131(16). PMC: 8363286. DOI: 10.1172/JCI144195. View